MJFF announces $10 million competition for Parkinson’s

News

Author: Simge Eva DoganPublished: 26 September 2019

Prep: Cook: Serves:

alpha-synuclein Parkinson's MJFF competition

The Michael J Fox Foundation has launched the ‘Ken Griffin Alpha-synuclein Imaging Competition’ – a US $10 million programme aiming to develop a game-changing tool for Parkinson’s research.

As part of the competition, participating teams will compete in a scientific race to build a device that is able to identify alpha-synuclein – a protein closely associated with Parkinson’s. Although almost everyone diagnosed with Parkinson’s has clumps of alpha-synuclein in the brain, these are currently only visible when analysing tissue during autopsies.

The competition is named after Ken Griffin, CEO of US investment firm Citadel who has given US $7.5 million funding to the programme.

Griffin – whose father has Parkinson’s – said: “If we have the imaging capability to observe the pathology that arises from protein-misfolding in real time, and understand how drugs are impacting people in real time, that would be a major advance.”

To read more on this topic click here.

MJFF announces $5 million grant to study Parkinson’s genetics in Africa, East Asia and India

Last Month

Next Month

Go Back

Share this story

Comments

Advances

App improves adherence to Parkinson’s meds

Patients using app are "10% more likely to take meds on time"

Tom Isaacs president of The Cure Parkinson’s Trust has died

"We're devastated but are focusing on his incredible achievements"

People with depression ‘more likely’ to develop Parkinson’s

Could depression be a warning sign for Parkinson's?

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

A new screening tool has been developed to support the early diagnosis of Parkinson’s disease psychosis – a symptom of the condition that is often misdiagnosed. Created by Canadian senior care software company, PointClickCare and membership organisation, the American Society of Consultant Pharmacists (ASCP), the platform asks questions on topics like hallucinations and delusions. Healthcare workers can then review the responses and decide to collect more information and create a care plan. Data collected through the tool will also be used to help scientific research in healthcare organisations. Bill Stuart, clinical product strategist at PointClickCare said: “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s psychosis.” Chad Worz, chief executive of ASCP, added: “We are excited to have another tool for care teams to facilitate a more standardised care process for Parkinson’s disease and we…

Has Covid-19 impacted access to Parkinson’s medication?

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease. The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors. The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication. “Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”

Brazilian dance could improve mobility in people with Parkinson’s, study finds

Researchers at the Federal University of Rio Grande do Sul in Brazil compared participants in a 12-week programme, inspired by samba and forró dances, with those in a walking exercise programme to measure improvement in their functional mobility and gait. The 18 participants had an average age of 68.6 and had all been diagnosed with Parkinson’s over a year ago. The results, published in journal BMC Neurology, found that both groups showed significant improvements in mobility and balance tests. Participants in the dance group showed increases in stride frequency at a self-chosen test speed and a reduced swing time (the amount of time the foot is off the floor) at a fast speed. The results indicated that dance was as “effective as walking in improving functional mobility”. The researchers wrote: “It is essential to find different activities that can offer benefits to individuals… so that they can engage in the…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

MJFF announces $10 million competition for Parkinson’s

News

Author: Simge Eva DoganPublished: 26 September 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

App improves adherence to Parkinson’s meds

Perspectives

Tom Isaacs president of The Cure Parkinson’s Trust has died

Advances

People with depression ‘more likely’ to develop Parkinson’s

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

{title}

Subscribe

MJFF announces $10 million competition for Parkinson’s

News

Author: Simge Eva DoganPublished: 26 September 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

App improves adherence to Parkinson’s meds

Perspectives

Tom Isaacs president of The Cure Parkinson’s Trust has died

Advances

People with depression ‘more likely’ to develop Parkinson’s

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

{title}

Subscribe

Sign in